Clinical patient trial
The CartRevive™ hydrogel implant is currently being validated in a clinical trial. This ACTIVE-study, Advanced Cartilage Treatment with Injectable hydrogel Validation of the Effect, is led by dr. R.J.H. Custers, orthopedic surgeon, department of orthopedics of the University Hospital Utrecht as the Principal Investigator.
If you are interested to participate in this study then please contact our Principal Investigator, dr. R.J.H. Custers via:
Participate in Active Study | Hy2Care®
By contacting the hospital for an appointment, you show your interest in participation in the study. However, this will not provide a guarantee that you are eligible for participation. Many factors may exclude you from participation; only the orthopedic surgeon who performs the examination will determine your eligibility.
The CartRevive™ hydrogel implant is an investigational implant designed for patients who are suffering from a relatively recent cartilage injury surrounded by healthy cartilage. It is NOT aimed at advanced stages of cartilage disease like OsteoArthritis or Rheumatoid Arthritis.
Hy2Care’s CartRevive™ hydrogel implant has not yet been approved by regulatory authorities for commercial sale and can only be used in a clinical study.